{"organizations": [], "uuid": "c56a0cbafe39bf12479bcdd5dd2030b1f2a88318", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180117.html", "section_title": "Archive News &amp; Video for Wednesday, 17 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-hemispherx-enters-sale-leaseback-a/brief-hemispherx-enters-sale-leaseback-agreement-for-nj-development-and-production-facility-idUSFWN1PC0T2", "country": "US", "domain_rank": 408, "title": "BRIEF-Hemispherx Enters Sale/Leaseback Agreement For NJ Development And Production Facility", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.037, "site_type": "news", "published": "2018-01-17T21:39:00.000+02:00", "replies_count": 0, "uuid": "c56a0cbafe39bf12479bcdd5dd2030b1f2a88318"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-hemispherx-enters-sale-leaseback-a/brief-hemispherx-enters-sale-leaseback-agreement-for-nj-development-and-production-facility-idUSFWN1PC0T2", "ord_in_thread": 0, "title": "BRIEF-Hemispherx Enters Sale/Leaseback Agreement For NJ Development And Production Facility", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "hemispherx biopharma inc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "nj development", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 17 (Reuters) - Hemispherx Biopharma Inc:\n* HEMISPHERX ENTERS INTO SALE/LEASEBACK AGREEMENT FOR NJ DEVELOPMENT AND PRODUCTION FACILITY\n* HEMISPHERX BIOPHARMA INC - UNDER TERMS OF AGREEMENT, HEMISPHERX IS SELLING THE REAL ESTATE FOR $4.0 MILLION\n* HEMISPHERX BIOPHARMA - UNDER TERMS OF AGREEMENT, SIMULTANEOUSLY ENTERING INTO A 10-YEAR LEASE WITH OPTIONS TO EXTEND LEASE FOR ANOTHER 10-YEARS Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-17T21:39:00.000+02:00", "crawled": "2018-01-18T16:01:39.013+02:00", "highlightTitle": ""}